Diversified Trust Co - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Diversified Trust Co ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$33,462
-80.3%
25,740
+13.4%
0.00%
-83.3%
Q4 2021$170,000
-16.7%
22,6960.0%0.01%
-14.3%
Q3 2021$204,000
-16.0%
22,696
+11.8%
0.01%
-22.2%
Q2 2021$243,000
-4.3%
20,2980.0%0.01%
-10.0%
Q1 2021$254,000
-24.4%
20,298
-5.6%
0.01%
-28.6%
Q4 2020$336,000
+73.2%
21,513
+4.9%
0.01%
+55.6%
Q3 2020$194,000
+5.4%
20,5050.0%0.01%0.0%
Q2 2020$184,000
-31.6%
20,505
+16.2%
0.01%
-59.1%
Q2 2014$269,00017,6440.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders